Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118275) titled 'Artificial Intelligence-powered Low-Dose Computed Tomography for Screening of Pancreatic Cancer' on Feb. 3.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: ShangHai ChangHai Hospital
Condition:
Pancreatic cancer
Intervention:
AI screening group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-02-03
Target Sample Size: AI screening group:200000;No AI screening group:200000;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=285685
Disclaimer: Curated by HT Syndication....